KR20110089180A - 직접 압축가능한 과립상 미세결정질 셀룰로스 기재 부형제, 그의 제조 방법 및 용도 - Google Patents

직접 압축가능한 과립상 미세결정질 셀룰로스 기재 부형제, 그의 제조 방법 및 용도 Download PDF

Info

Publication number
KR20110089180A
KR20110089180A KR1020117013939A KR20117013939A KR20110089180A KR 20110089180 A KR20110089180 A KR 20110089180A KR 1020117013939 A KR1020117013939 A KR 1020117013939A KR 20117013939 A KR20117013939 A KR 20117013939A KR 20110089180 A KR20110089180 A KR 20110089180A
Authority
KR
South Korea
Prior art keywords
binder
microcrystalline cellulose
slurry
excipient
disintegrant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020117013939A
Other languages
English (en)
Korean (ko)
Inventor
난두 데오르카르
제임스 파리나
릴리아나 미니아
사미어 란디브
Original Assignee
아반토르 퍼포먼스 머티리얼스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아반토르 퍼포먼스 머티리얼스, 인크. filed Critical 아반토르 퍼포먼스 머티리얼스, 인크.
Publication of KR20110089180A publication Critical patent/KR20110089180A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
KR1020117013939A 2008-11-19 2009-11-16 직접 압축가능한 과립상 미세결정질 셀룰로스 기재 부형제, 그의 제조 방법 및 용도 Ceased KR20110089180A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11602508P 2008-11-19 2008-11-19
US61/116,025 2008-11-19

Publications (1)

Publication Number Publication Date
KR20110089180A true KR20110089180A (ko) 2011-08-04

Family

ID=42077071

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117013939A Ceased KR20110089180A (ko) 2008-11-19 2009-11-16 직접 압축가능한 과립상 미세결정질 셀룰로스 기재 부형제, 그의 제조 방법 및 용도

Country Status (13)

Country Link
US (1) US20110288146A1 (enExample)
EP (1) EP2376067A2 (enExample)
JP (1) JP2012509329A (enExample)
KR (1) KR20110089180A (enExample)
CN (1) CN102215825A (enExample)
AU (1) AU2009316812A1 (enExample)
BR (1) BRPI0921507A2 (enExample)
CA (1) CA2744142A1 (enExample)
IL (1) IL212955A0 (enExample)
MX (1) MX2011005168A (enExample)
SG (1) SG171752A1 (enExample)
TW (1) TW201023897A (enExample)
WO (1) WO2010059534A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101298788B1 (ko) * 2011-03-15 2013-08-22 보령제약 주식회사 안정성이 개선된 복합제제
EP2842986B1 (en) * 2012-04-27 2018-12-26 Japan Corn Starch Co., Ltd. Method for producing starch granules, and orally disintegrating tablet
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
MX2015010315A (es) 2013-03-14 2016-04-13 Aimmune Therapeutics Inc Fabricacion de formulaciones de mani para desensibilizacion oral.
US20150343075A1 (en) * 2014-06-02 2015-12-03 Aimmune Therapeutics Placebo formulations and uses thereof
CN104189915B (zh) * 2014-07-30 2016-08-10 上海新亚药业闵行有限公司 一种固体制剂预混剂及其制备方法
CN104258411A (zh) * 2014-09-19 2015-01-07 安徽山河药用辅料股份有限公司 一种硅化微晶纤维素复合辅料及其制备方法
CN106265077A (zh) * 2015-05-30 2017-01-04 天士力制药集团股份有限公司 一种中药浸膏雾化分散工艺及其制剂
JP6650750B2 (ja) * 2015-12-22 2020-02-19 アサヒグループ食品株式会社 錠剤の製造方法、錠剤原料用顆粒の製造方法、及び錠剤原料用顆粒
US12433945B2 (en) 2018-08-16 2025-10-07 Société des Produits Nestlé S.A. Peanut oral immunotherapy with maintenance dose
CA3123605A1 (en) 2018-12-20 2020-06-25 Aimmune Therapeutics, Inc. Peanut oral immunotherapy dosing schedule for missed doses
CA3137295A1 (en) 2019-05-10 2020-11-19 Aimmune Therapeutics, Inc. Methods for improving the quality of life of a patient with a peanut allergy
PH12021553026A1 (en) 2019-07-05 2023-08-23 Swedish Match North Europe Ab An oral pouched nicotine product including a filling material comprising nicotine-containing particles
HRP20231531T1 (hr) 2019-11-20 2024-03-01 Swedish Match North Europe Ab Nikotinski proizvod u vrećici za oralnu upotrebu koji uključuje materijal za punjenje koji sadržava čestice nikotina
EP4018848B1 (en) 2020-12-22 2024-09-18 Swedish Match North Europe AB A pouched product for oral use comprising a liquid permeable cover material and a filling material
CN116036291B (zh) * 2022-08-31 2025-08-26 瑞普（天津）生物药业有限公司 一种具有增溶作用的组合物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
CA2126441C (en) * 1991-12-30 1999-12-21 David F. Erkoboni Microcrystalline cellulose spheronization composition
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
DE19628617A1 (de) * 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel
DE59914598D1 (de) * 1999-07-19 2008-02-14 Fit Gmbh Coprozessiertes Polysaccharidprodukt mit unlöslicher Carboxymethylcellulose
CN1222318C (zh) * 2000-11-06 2005-10-12 旭化成株式会社 制剂用纤维素粒子
CA2437375A1 (en) * 2001-02-05 2002-08-15 R.P. Scherer Technologies, Inc. Methods and compositions for reducing the taste of pharmaceutically active agents
CA2644400C (en) * 2005-02-03 2014-04-08 Nycomed Pharma As Fast wet-massing method for the preparation of calcium-containing compositions
WO2008020990A1 (en) * 2006-08-09 2008-02-21 Mallinckrodt Baker, Inc. New direct compressible excipient blend
DE602007011792D1 (de) * 2006-10-27 2011-02-17 Fmc Corp Gemeinsam aufbereitete mikrokristalline cellulose und zuckeralkohol als hilfsstoff für tablettenformulierungen
WO2009048557A1 (en) * 2007-10-10 2009-04-16 Mallinckrodt Baker, Inc. Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof

Also Published As

Publication number Publication date
SG171752A1 (en) 2011-07-28
CA2744142A1 (en) 2010-05-27
MX2011005168A (es) 2011-05-30
TW201023897A (en) 2010-07-01
JP2012509329A (ja) 2012-04-19
CN102215825A (zh) 2011-10-12
US20110288146A1 (en) 2011-11-24
WO2010059534A3 (en) 2011-01-20
IL212955A0 (en) 2011-07-31
BRPI0921507A2 (pt) 2016-01-19
AU2009316812A1 (en) 2011-07-07
EP2376067A2 (en) 2011-10-19
WO2010059534A2 (en) 2010-05-27

Similar Documents

Publication Publication Date Title
US20110288146A1 (en) Directly compressible granular microcrystalline cellulose based, excipient, manufacturing process and use thereof
KR20110086741A (ko) 직접 압축가능한 고 기능성 과립상 이염기성 인산칼슘 기재 공-가공된 부형제
US20170112768A1 (en) Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
EP2207533B1 (en) Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
RS57525B1 (sr) Vlažna granulacija upotrebom agensa za izolovanje vode
KR101033975B1 (ko) 직접압축법을 이용한 발사르탄 함유 고형 경구 제형의 제조방법 및 이에 따라 제조된 고형 경구 제형
JP5711969B6 (ja) 直接圧縮可能な高機能性の顆粒状の微結晶性セルロースベースの賦形剤、製造工程およびその使用
US20120100211A1 (en) Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
HK40130660A (en) Solid formulations comprising an inhibitor of the k-ras protein having a g12c mutation, and a process for preparing
JP2011500565A5 (enExample)

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110617

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20141114

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150930

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160531

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20150930

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I